GeneDx is a genetic testing company that specializes in advanced genomic testing, particularly for rare and ultra-rare genetic disorders. The stock has surged over 2,500% since the start of 2024, making it one of the year’s top performers. This steep growth reflects the company’s reported success in significantly increasing revenue while stemming its cash burn. We believe the company’s growth is largely an illusion, driven by fraudulent schemes and illegal tactics deliberately aimed at exploiting Medicaid and Medicare systems to artificially inflate revenue.,
More ... latest change: 2026-02-08
last updated: